EntryPoint Capital LLC Sells 4,613 Shares of DocGo Inc. (NASDAQ:DCGO)

EntryPoint Capital LLC trimmed its holdings in shares of DocGo Inc. (NASDAQ:DCGO) by 19.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,683 shares of the company’s stock after selling 4,613 shares during the period. EntryPoint Capital LLC’s holdings in DocGo were worth $80,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. AJOVista LLC bought a new position in shares of DocGo during the fourth quarter valued at approximately $25,000. Cape Investment Advisory Inc. purchased a new stake in DocGo during the fourth quarter worth $63,000. Intrust Bank NA bought a new stake in DocGo during the 4th quarter valued at $85,000. Verdence Capital Advisors LLC bought a new stake in DocGo during the 1st quarter valued at $64,000. Finally, Tower Research Capital LLC TRC increased its holdings in shares of DocGo by 181.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 16,646 shares of the company’s stock valued at $93,000 after acquiring an additional 10,738 shares during the period. Hedge funds and other institutional investors own 56.44% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on DCGO. Stifel Nicolaus dropped their price objective on DocGo from $8.00 to $6.50 and set a “buy” rating on the stock in a research report on Tuesday, April 30th. BTIG Research cut their price objective on shares of DocGo from $11.00 to $7.00 and set a “buy” rating on the stock in a research report on Thursday, May 9th. Cantor Fitzgerald reduced their price objective on shares of DocGo from $11.00 to $5.00 and set an “overweight” rating for the company in a research note on Thursday, May 9th. Canaccord Genuity Group decreased their target price on shares of DocGo from $9.00 to $5.00 and set a “buy” rating for the company in a research report on Thursday, May 9th. Finally, Needham & Company LLC cut their price target on shares of DocGo from $10.00 to $7.00 and set a “buy” rating on the stock in a report on Thursday, May 9th. Five analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $7.75.

Insider Buying and Selling

In other news, General Counsel Ely D. Tendler purchased 10,000 shares of the company’s stock in a transaction on Monday, May 13th. The shares were acquired at an average price of $3.13 per share, for a total transaction of $31,300.00. Following the purchase, the general counsel now owns 162,933 shares in the company, valued at $509,980.29. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. In other news, General Counsel Ely D. Tendler acquired 10,000 shares of DocGo stock in a transaction dated Monday, May 13th. The stock was purchased at an average cost of $3.13 per share, for a total transaction of $31,300.00. Following the completion of the purchase, the general counsel now directly owns 162,933 shares in the company, valued at approximately $509,980.29. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Lee Bienstock bought 25,000 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The stock was purchased at an average price of $3.15 per share, for a total transaction of $78,750.00. Following the transaction, the chief executive officer now owns 1,220,845 shares of the company’s stock, valued at $3,845,661.75. The disclosure for this purchase can be found here. 2.70% of the stock is currently owned by company insiders.

DocGo Stock Up 5.4 %

Shares of DocGo stock opened at $3.74 on Friday. The firm has a market capitalization of $379.87 million, a P/E ratio of 18.70, a PEG ratio of 1.77 and a beta of 0.91. DocGo Inc. has a 52 week low of $2.75 and a 52 week high of $10.82. The company has a 50 day moving average price of $3.09 and a 200 day moving average price of $3.42.

DocGo (NASDAQ:DCGO) last posted its quarterly earnings results on Wednesday, May 8th. The company reported $0.09 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.09. DocGo had a net margin of 2.98% and a return on equity of 6.20%. The business had revenue of $192.09 million during the quarter, compared to analysts’ expectations of $185.36 million. As a group, research analysts anticipate that DocGo Inc. will post 0.24 earnings per share for the current fiscal year.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.